Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese men

被引:12
作者
El-Saed, Airnan [1 ]
Sekikawa, Akira [1 ,2 ]
Zaky, Riad Wahid [1 ]
Kadowaki, Takashi [2 ]
Takamiya, Tornoko [1 ]
Okamura, Tornonori [2 ]
Edmundowicz, Daniel [2 ,3 ]
Kita, Yoshikuni [2 ]
Kuller, Lewis H. [1 ]
Ueshima, Hirotsup [2 ]
机构
[1] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA
[2] Shiga Univ Med Sci, Dept Hlth Sci, Shiga, Japan
[3] Univ Pittsburgh, Med Ctr Hlth Plan, Cardiovasc Inst, Pittsburgh, PA 15260 USA
关键词
atherosclerosis; 1-alkyl-2-acetylglycerophosphocholine esterase; coronary arteriosclerosis; calcification; Asian continental ancestry group; European continental ancestry group; ACTIVATING-FACTOR-ACETYLHYDROLASE; C-REACTIVE PROTEIN; MIDDLE-AGED MEN; ARTERY-DISEASE; HEART-DISEASE; RISK-FACTORS; COMPUTED-TOMOGRAPHY; FOLLOW-UP; PAF-AH; A(2);
D O I
10.2188/jea.17.179
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BACKGROUND: We have previously reported that the prevalence of coronary artery calcification (CAC) was substantially lower among Japanese than American men despite a less favorable profile of many traditional risk factors in Japanese men. To determine whether lipoprotein-associated phospholipase A2 (Lp-PLA2) levels are related to the difference in the prevalence of CAC between the two populations. METHODS: A total of 200 men aged 40-49 years were examined: 100 residents in Allegheny County, Pennsylvania, United States, and 100 residents in Kusatsu City, Shiga, Japan. Coronary calcium score (CCS) was evaluated by electron-beam tomography, Lp-PLA2 levels, nuclear magnetic resonance (NMR) lipoprotein subclasses, and other factors were assessed in 2001-2002. RESULTS: Lp-PLA2 levels were higher among American than Japanese men (Mean standard deviation 301.7 +/- 82.6 versus 275.9 +/- 104.7 ng/mL, respectively, p=0.06). Among all Japanese men and those with low density lipoprotein (LDL) cholesterol >= 130 mg/dL, there was an inverse association of the prevalence of CCS>0 with the tertile groups of Lp-PLA2 levels (p=0.08 and p=0.03, respectively). American men did not have any association between CCS>0 with the tertile groups of Lp-PLA2 (p=0.62). Although Lp-PLA2 among both populations correlated positively with LDL and total cholesterol, American and Japanese men had different correlations with NMR lipoprotein subclasses. Reported high odds ratio for CCS>0 among American compared to Japanese men was not reduced after adjusting for Lp-PLA2 levels. CONCLUSION: Lp-PLA2 may have different mechanisms of action among American and Japanese men. Lp-PLA2 levels can not explain the observed CAC differences between the two populations.
引用
收藏
页码:179 / 185
页数:7
相关论文
共 23 条
[1]   QUANTIFICATION OF CORONARY-ARTERY CALCIUM USING ULTRAFAST COMPUTED-TOMOGRAPHY [J].
AGATSTON, AS ;
JANOWITZ, WR ;
HILDNER, FJ ;
ZUSMER, NR ;
VIAMONTE, M ;
DETRANO, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (04) :827-832
[2]   Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [J].
Ballantyne, CM ;
Hoogeveen, RC ;
Bang, H ;
Coresh, J ;
Folsom, AR ;
Heiss, G ;
Sharrett, AR .
CIRCULATION, 2004, 109 (07) :837-842
[3]   A prospective evaluation of lipoprotein-associated phospholipase A2 levels and the risk of future cardiovascular events in women [J].
Blake, GJ ;
Dada, N ;
Fox, JC ;
Manson, JE ;
Ridker, PM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (05) :1302-1306
[4]   Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up [J].
Brilakis, ES ;
McConnell, JP ;
Lennon, RJ ;
Elesber, AA ;
Meyer, JG ;
Berger, PB .
EUROPEAN HEART JOURNAL, 2005, 26 (02) :137-144
[5]   Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase:: a potential new risk factor for coronary artery disease [J].
Caslake, MJ ;
Packard, CJ ;
Suckling, KE ;
Holmes, SD ;
Chamberlain, P ;
Macphee, CH .
ATHEROSCLEROSIS, 2000, 150 (02) :413-419
[6]   A mutation in plasma platelet-activating factor acetylhydrolase (Val(279)->Phe) is a genetic risk factor for stroke [J].
Hiramoto, M ;
Yoshida, H ;
Imaizumi, T ;
Yoshimizu, N ;
Satoh, K .
STROKE, 1997, 28 (12) :2417-2420
[7]   Association of lipoprotein-associated phospholipase A2 mass and activity with calcified coronary plaque in young adults -: The CARDIA study [J].
Iribarren, C ;
Gross, MD ;
Darbinian, JA ;
Jacobs, DR ;
Sidney, S ;
Loria, CM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (01) :216-221
[8]   Plasma platelet activating factor-acetylhydrolase (PAF-AH) [J].
Karasawa, K ;
Harada, A ;
Satoh, N ;
Inoue, K ;
Setaka, M .
PROGRESS IN LIPID RESEARCH, 2003, 42 (02) :93-114
[9]  
KARDYS I, 2006, ATHEROSCLEROSIS 0503
[10]   Association between Lp-PLA2 and coronary artery disease:: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis [J].
Khuseyinova, N ;
Imhof, A ;
Rothenbacher, D ;
Trischler, G ;
Kuelb, S ;
Scharnagl, H ;
Maerz, W ;
Brenner, H ;
Koenig, W .
ATHEROSCLEROSIS, 2005, 182 (01) :181-188